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AbstrACt
background Preterm birth causes long-term problems, 
even for infants born 1 or 2 weeks early. However, less is 
known about infants born after their due date and over a 
quarter of infants are born over 1 week late, and many still 
remain undelivered after 2 weeks. The aim of this work is 
to quantify the risks of infants developing encephalopathy 
when birth occurs after the due date, and if other proposed 
risk factors modify this relationship.
Methods The dataset contain information on 4 036 346 
infants born in Sweden between 1973 and 2012. Exposure 
was defined as birth 7, or more, days after the infants’ 
due date. The primary outcome was the development 
of neonatal encephalopathy (defined as seizures, 
encephalopathy or brain injury caused by asphyxia or with 
unspecified cause). Covariates were selected as presumed 
confounders a priori.
results 28.4% infants were born 1 or more weeks 
after their due date. An infant’s risk of being born with 
encephalopathy was higher in the post 41 weeks group in 
the unadjusted (OR 1.40 (95% CI 1.32 to 1.49)) and final 
model (OR 1.38 (95% CI 1.29 to 1.47)), with the relative 
odds of encephalopathy increasing by an estimated 20% 
per week after the due date, and modified by maternal age 
(P=0.022).
Conclusions Singleton infants born at, or after, 41 
weeks gestation have lower Apgar scores and higher risk 
of developing encephalopathy in the newborn period, and 
the association appeared more marked in older mothers. 
These data could be useful if provided to women as part of 
their decision-making.
IntroduCtIon
Preterm birth causes long-term problems, even 
for infants born 1 or 2 weeks early. However, 
less is known about infants born after their 
due date and over a quarter of infants are 
born over 1 week late, and many still remain 
undelivered after 2 weeks. While there is a 
plethora of work investigating the long-term 
cognitive, educational and social functioning 
of babies born prematurely,1 2 little data exist 
for the outcomes of those infants born after 
their due date or the mechanisms of any 
possible adverse outcomes.3 
Perinatal asphyxia (deprivation of oxygen 
during birth) is a relatively common event 
with around 7% of infants needing support 
after birth.4 While most infants tolerate it well, 
a small proportion, around 0.2%4 of these 
develop immediate signs of brain damage 
(hypoxic–ischaemic encephalopathy).5 The 
clinical impacts can be lifelong and devas-
tating for them and their family; the litigation 
and societal costs notwithstanding.6 The risks 
of perinatal asphyxia may increase in infants 
born after their due date,3 but estimates are 
conflicting.7 However, in contrast to preterm 
birth, interventions can be used to deliver 
the infant if the risks of continuing the preg-
nancy are higher than delivery for either the 
mother or the infant. Indeed, induction of 
labour (IOL) has been shown to be benefi-
cial in high-risk groups,8–11 but its place in the 
management of infants past their due date is 
unclear.11 12
What is already known on this topic?
 ► Preterm birth causes long-term problems, but less 
is known about infants born after their due date.
 ► Perinatal asphyxia may increase as infants pass 
their due date, but estimates are conflicting and 
imprecise.
 ► A current research priority is to try to identify babies 
at particularly high risk of morbidity and mortality 
who will benefit from induction.
What this study hopes to add?
 ► The risks of developing perinatal encephalopathy 
increase among infants that remain in utero after 
their due date.
 ► The association was observed in the most recent 
data, in younger and older mothers and in well-
grown infants.
 ► However, this increase in risk is higher in women 
over 35 years old.
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This dearth of data makes counselling for women 
difficult and consequently the management of pregnan-
cies beyond term varies hugely between units and coun-
tries (eg, 0.4% in Austria vs 7% in Denmark).13 Current 
National Institute for Health and Clinical Excellence 
guidelines suggest that a research priority is to ‘identify 
babies at particularly high risk of morbidity and mortality 
who will benefit from induction and therefore avoid 
induction for babies who do not need it’14—the primary 
aim of this work. However, even small improvements in 
outcomes would yield substantial health benefits for indi-
viduals and economic benefits for health services and 
society.
The aim of this work is to quantify the risks of devel-
oping perinatal encephalopathy or being born with low 
Apgar score (less than 7 at 5 min), when born 7 or more 
days after their due date (at, or after, 41 completed weeks 
of gestation).
Methods
Population
The dataset reviewed contains information on 
4 036 346 infants born in Sweden between 1973 and 
2012 and registered on the nationwide birth registry of 
Sweden. The birth registry provides data on 98%–99% of 
births and includes Apgar scores, as well as both neonatal 
and maternal diagnoses (coded using the International 
Classification of Diseases (ICD), 8th, 9th and 10th revi-
sions). Details of the clinical signs that led to the diag-
noses are not recorded.
Infants born before 37 weeks gestation (n=234 924), 
from multiple births (n=56 493) or with cardiovascular, 
respiratory, neurological or multiple system congen-
ital abnormalities (n=29 535) were removed, leaving 
3 715 394 infants for the study. Infants with missing data 
on Apgar score or gestational age (n=7715) and those 
with missing data on at least one covariate (n=280 229) 
were also removed, leaving 3 427 450 subjects available 
for the analyses (92% of eligible subjects) (online supple-
mentary appendix 1).
Information on birth condition and perinatal well-
being was retrieved from the birth registry. The exposure 
was defined as birth 7, or more, days after the infants’ due 
date (≥41 weeks gestation). A primary outcome was the 
development of likely perinatal encephalopathy (defined 
as an ICD coding for either ‘seizures’, ‘encephalopathy’ 
or brain injury caused by ‘asphyxia’ or with ‘unspecified 
cause’ immediately after birth).15 Secondary outcomes 
were Apgar scores at 1, 5 and 10 min, or a low Apgar score 
at 5 min (less than 7).16
Potential confounders and covariates
Covariates were selected as presumed confounders a 
priori,17 and categorised into three groups: (1) social 
(maternal age, maternal occupation, maternal educa-
tion), (2) antenatal (infant gender and primiparity) and 
(3) intrapartum and potential causal factors (maternal or 
infant infection, birth weight (gram), birth by caesarean 
section).
statistical analysis
Initially, subjects with and without missing data were 
compared. The distribution of risk factors and potential 
confounders was investigated between the infants split 
by their gestation at birth. In univariable analysis the 
mean Apgar score at 1, 5 and 10 min, and the risk of 
developing encephalopathy was derived, split by each 
completed week of gestation. Due to the non-normal 
distribution of the Apgar score, geometric means (with 
95% CIs) were derived. Birth weight and maternal age 
were treated as continuous variable and not grouped 
further beyond their initial units (grams and years, 
respectively).
In the multivariable analyses, linear (for Apgar scores) 
and logistic regression (for encephalopathy and a low 
Apgar score at 5 min) models were used to assess any 
association with gestational age at birth. To account for 
changes in coding over time, models were multilevel 
to account for year of birth. Adjustment for social and 
antenatal confounders was performed by adding the 
variables described above to the models in blocks of 
common variables (defined above). Variables with poten-
tial confounding influence, but with possible causal 
inference, were introduced in a final model. The impact 
of birth at ≥41 weeks gestation on encephalopathy was 
calculated using the population attributable risk from 
this model.
Five sensitivity analyses were performed:
1. The model was repeated using the number of weeks 
of birth after the due date as an ordinal variable.
2. The model was repeated limiting the analysis to well 
grown (over 2500 g at birth) infants.
3. The model was repeated, testing if maternal age 
(greater than 35 years of age), interacted with the as-
sociation between birth ≥41 weeks gestation and risk 
of encephalopathy.
4. The model was repeated, restricting the analysis to the 
most recent 10 years of data (2003–2012).
5. The model was repeated using an imputation 
technique (multiple imputation using chained 
equations) to impute missing covariate values. 
Exposure and outcome data (eg, encephalopathy 
or gestational age data) was not imputed. Because 
of computation limitations, only a random 10% of 
infants without encephalopathy were included in this 
analysis to maintain a practical sized dataset, and the 
model weighted to represent the initial population 
(20 datasets with 42 102 infants in each).
All analyses were conducted with Stata V.10.0 soft-
ware (StataCorp), and results are presented as number 
(per cent), mean (SD), OR (95% CI) or median (IQR) 
as appropriate. Due to using registry data, informed 
consent was not obtained, and all data were provided and 
analysed anonymously.
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results
Infants with missing data weighed less and had older 
mothers (online supplementary appendix 2). Infants 
excluded with missing data were likely to have missing 
data for multiple variables. They were less likely to be 
exposed to pre-eclampsia, but more likely to have been 
exposed to maternal or neonatal infection. Mothers were 
more likely to have been nulliparous, and had a different 
profile of occupations and educational achievements 
(all comparisons P<0.001). There was no difference in 
gender (P=0.726) or risk of encephalopathy (P=0.136) 
between those with or without complete data.
In total, 973 430 (28.4%) infants were born 1 or more 
weeks after their due date. Over the 40-year period, 
there was a slight reduction in the (geometric) mean 
in the population from 40.1 (40.0–40.1) in 1973 to 39.6 
(39.6–39.6) (P<0.001) in 2012. Populations were similar, 
although infants born ≥41 weeks gestation were more 
likely to be male, had greater birth weight and were less 
likely to be exposed to maternal pre-eclampsia, or be 
born by caesarean section (table 1). They were also more 
likely to develop maternal or neonatal infection. Mothers 
were younger, more likely to be nulliparous, and had a 
different profile of occupations and educational qual-
ifications (all comparisons P<0.001). Due to the large 
numbers in the dataset differences were often small and 
of questionable clinical relevance.
There was strong evidence that the mean Apgar score 
at 1, 5 and 10 min reduced as the infants gestational 
age continued beyond 39 weeks (figure 1 and table 2, 
all P<0.001), although the magnitude of the difference 
in mean values was small. In addition, the risk of being 
born with a low Apgar score and the risk of developing 
encephalopathy became greater as the infants gestational 
age increased (both P<0.001). Interestingly, infants born 
at 37 weeks also appeared to have lower Apgar scores 
and higher rates of encephalopathy than infants born 
at 39 or 40 weeks gestation (post hoc analysis; P<0.001). 
Infants born at 45 weeks gestation appeared to have the 
lowest rate of encephalopathy, however, this is based on 
only one infant developing encephalopathy and hence 
the CIs are wide around the point estimate (0.07% (95% 
CI −0.07% to 0.20%)) and this observation needs to be 
interpreted with caution.
Overall, infants born ≥41 weeks gestation were more 
likely to develop encephalopathy than those born before 
41 weeks gestation (3040 (0.12%) vs 1640 (0.17%), 
P<0.001). In the unadjusted results, the mean Apgar 
scores at 1, 5 and 10 min were lower in infants born ≥41 
weeks gestation and this persisted after adjustment for a 
priori defined confounders, and remained after adjusting 
for both confounders and other causal factors (table 3). 
The risk of encephalopathy showed a similar association, 
with an infant’s risk of being born with encephalopathy 
Table 1 Characteristics of the study population according to gestational age at birth (n=3 427 450)
Measure 37+0 to 40+6 weeks 41+0 and above Difference (95% CI)
Antenatal factors
  Male 1 244 878 (50.7%) 511 567 (52.6%) 1.82% (1.71% to 1.94%)
  Birth weight (g) 3511 (473) 3798 (474) 288 (287 to 289)
  Maternal pre-eclampsia 115 578 (4.7%) 38 693 (4.0%) −0.07% (−0.08% to 0.07%)
Intrapartum factors
  Maternal infection 16 092 (0.66%) 7240 (0.74%) 0.09% (0.07% to 0.11%)
  Neonatal infection 10 334 (0.4%) 6125 (0.6%) 0.21% (0.19% to 0.22%)
  Caesarean section 294 707 (12.1%) 85 400 (8.8%) −3.24% (−3.31% to −3.16%)
Demographic factors
  Maternal age 28.1 (5.2) 27.8 (5.1) −0.30 (−0.31 to −0.29)
  Primiparae 995 171 (40.6%) 450 385 (46.3%) 5.72% (5.60% to 5.83%)
  Maternal occupation
   Manual 793 546 (32.3%) 314 211 (32.3%) −0.06% (−0.17% to 0.05%)
   Non-manual 868 071 (35.4%) 371 740 (38.2%) 2.82% (2.70% to 2.93%)
   Other 792 403 (32.3%) 287 479 (29.5%) −2.86% (−2.87% to −2.65%)
  Maternal education status
   <9 years 71 148 (2.9%) 28 652 (2.9%) 0.04% (0.04% to 0.08%)
   9–10 years 919 214 (37.5%) 364 418 (37.4%) −0.02% (−0.01% to 0.09%)
   Full secondary 465 920 (19.0%) 177 561 (18.2%) −0.75% (−0.84% to −0.65%)
   Higher education 997 738 (40.7%) 402 799 (41.4%) 0.72% (0.61% to 0.84%)
Values are number (per cent), mean (±SD) or difference (95% CI) as appropriate.
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higher if they were born 1 or more weeks after their due 
date, in the unadjusted (OR 1.40 (95% CI 1.32 to 1.49)) 
and adjusted analysis (OR 1.34 (95% CI 1.26 to 1.42)), 
and also persisted in the model controlling for potential 
causal factors (OR 1.38 (95% CI 1.29 to 1.47)). The risk 
of a low (<7) 5 min Apgar score showed similar results (all 
comparisons; P<0.001). The population attributable risk 
fraction of infants who developed encephalopathy at, or 
after, 41 weeks gestation was 4.6%.
Using birth after the due date as an ordinal variable 
(eg, 1 week over at 41 weeks, 2 weeks at 42 weeks, etc) 
demonstrated similar results to the main analysis: for 
each week after the due date that the infant stayed in 
utero, there was an associated increase in the risk of 
developing neonatal encephalopathy (OR 1.22 (95% CI 
1.18 to 1.27)).
Repeating the model after restricting to well-grown 
infants (OR 1.36 (95% CI 1.28 to 1.46)) or to the most 
recent 10 years of data (OR 1.35 (95% CI 1.20 to 1.52)) 
provided very similar results.
There was evidence that maternal age modified 
the association between later birth and encephalop-
athy (P=0.022). Mothers aged 35 years and older had 
a higher risk that birth ≥41 weeks would result in an 
infant with encephalopathy (OR 1.67 (95% CI 1.40 to 
1.98)) compared with those who were younger than 
35 (OR 1.34 (95% CI 1.25 to 1.43)). A multiple impu-
tation model including all infants with exposure and 
outcome date (n=7 17 801, adjusted OR 1.41 (95% CI 
1.31 to 1.51)) also produced similar results to the main 
analysis. A final, post hoc analysis was performed due 
to the possible non-linear association of gestational age 
and encephalopathy. Infants were split by gestation age 
into three exposure groups; early (37/38 weeks), within 
7 days of the due date (39/40 weeks) and late (≥41 
weeks). Infants born at 37/38 weeks (OR 1.30 (95% CI 
1.20 to 1.40) and ≥41 weeks (OR 1.50 (95% CI 1.40 to 
1.60)) both demonstrated higher risks of encephalop-
athy than those born within 7 days of their due date in 
the unadjusted analysis, but the effect was only seen in 
those ≥41 weeks after correction for potential confounders 
(OR 1.01 (95% CI 0.93 to 1.10) and OR 1.38 (95% CI 
1.29 to 1.48), respectively).
dIsCussIon
We have demonstrated, in a large population-based 
dataset, that the risks of developing perinatal encepha-
lopathy increases significantly for each week that preg-
nancies continue after their due date. Assuming that 
gestational age is accurately assessed and intrapartum 
care of pregnancies is similar for the gestational age at 
birth, then this effect may be readily preventable if this 
association is causal. Indeed, sensitivity analysis suggests 
that the relative risk of encephalopathy increases by an 
estimated 20% per week among infants that remain in 
utero after their due date (compared with infants born 
at, or before it). The association appeared robust, as it 
was observed in the most recent data, in younger and 
older mothers and in well-grown infants.
Limitations of this work include the use of routine 
data, and the number of infants excluded from the 
analysis due to missing data points. Likely perinatal 
encephalopathy was defined using available neonatal 
ICD codes consistent with our previous work,6 but may 
also include infants with other neurological disease, 
Figure 1 Mean Apgar scores, split by gestational age at birth.
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and does not identify if the infants were admitted to 
a neonatal intensive care unit (NICU) or not. As a 
routine data source, it is difficult to use the ICD codes 
to further interrogate the individual reasons for the 
neurological signs and some uncertainty about the 
underlying biological causes, and the assumption that 
it can be reversed by earlier delivery must remain. 
Equally, we did not have information on the indication 
for operative deliveries or IOL; although this is likely to 
cause us to underestimate any impact of postdue date 
delivery and this use of routine data is likely to weaken 
any association seen due to misclassification. However, 
the birth registry is considered a robust source of infor-
mation, thus minimising any effect seen rather than 
introducing false positive findings. In particular, the 
measurement of gestational age in this cohort may 
be less accurate than modern measures available to 
clinicians and the methods used to derive it (initially 
clinical measure of last menstrual period, followed by 
ultrasound dating) have changed over the study period. 
However, while diagnostic criteria may have changed 
over the study period, the models used random effects 
to account in part for this, and results from the most 
recent years showed similar results to those from the 
whole cohort.
The groups of infants did appear to vary on a number 
of clinical factors (eg, infection risk), however, the 
cohort was large, and able to show differences in clin-
ical characteristics (eg, a 2–3 months difference in 
maternal age) of minor magnitude and of question-
able clinical significance. Overall, we saw little evidence 
for confounding in this work, but it should be noted 
that residual and uncontrolled confounding remain a 
limitation of any non-randomised study. With respect 
to missing data, we have attempted to investigate the 
impact using a multiple imputation technique, which 
produced almost identical results to the main analysis, 
although again, any interpretation of the results should 
consider this limitation.
This work suggests an increase in significant morbidity 
in infants born after more than 41 weeks gestation, and 
it seems plausible that the presumed deterioration in the 
in utero environment for the foetuses also contributes to 
the known risk of late stillbirth; possibly placental insuffi-
ciency. Alternatively we identified an increase in the risk 
of infection in the later-born infants (0.6% vs 0.4%) which 
may have contributed to seizures or low Apgar scores, 
although this association persisted after adjustment for 
it in the final model. It should be noted that infants over 
43 weeks gestation appeared to have slightly higher 1 min 
Apgar scores (but not 5 or 10 min) than other post-term 
infants. Whether this was a statistical imprecision due to 
the low numbers in these groups or evidence that the 
score may be a less reliable measure of birth condition 
than the later measures is unclear.
It seems possible that IOL or caesarean section at 
40 weeks gestation may improve morbidity and mortality, 
although we were unable to investigate perinatal deaths in T
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this work. However, early birth particularly by caesarean 
section is not without risk; in addition to respiratory 
morbidity, recent work suggests poorer long-term cogni-
tive outcomes may occur for infants born just 2 weeks 
early,8 although we were unable to demonstrate a higher 
risk of encephalopathy in infants born before 38 weeks 
(after adjustment for confounders).
There is particular concern with regard to the risks asso-
ciated with pregnancies continuing in older women,18 
and this work demonstrates a higher risk in women over 
35 years old. Furthermore, a recent interventional study 
for women aged over 35 years concluded that IOL at 
39 weeks of gestation, as compared with expectant 
management, had no significant effect on the rate of 
caesarean section and no adverse short-term effects on 
maternal outcomes. However, that study was underpow-
ered for neonatal outcomes.19 A recent systematic review 
demonstrating reductions in caesarean rates for women 
induced at term also showed that there was a reduced risk 
of fetal death and admission to NICUs with IOL.10
Despite these findings, there is no general consensus 
on whether IOL should be offered to all women at 
40 weeks gestation.11 12 Factors that should be considered 
before advocating such a recommendation would include 
the accuracy of the gestational age measurements, and 
impact of the induction process on a woman’s birth 
experience.14 Indeed, midwives or obstetricians may be 
reticent to recommend an earlier intervention for risk of 
over medicalising normal pregnancies. There may also 
be implications on workload and capacity if women were 
to accept earlier IOL.
The results from this study provide further evidence 
to support elective IOL during the 39th or 40th week 
of gestation. However, more randomised trials of IOL at 
40 weeks gestation versus expectant management need 
to be conducted to obtain prospective data on long-
term neonatal and maternal outcomes. More research 
is required in this area, including work looking at the 
role of membrane sweeping or more formal induction 
processes, as well as quantifying any long-term conse-
quences to the infant.
ConClusIon
Singleton infants born at, or after, 41 weeks gestation 
have a higher risk of developing encephalopathy in the 
newborn period. Expediting birth at 40 weeks gestation, 
including IOL, could prevent a substantial proportion 
(up to 5% (based on the estimated population attribut-
able risk)) of all neonatal encephalopathy. These poor 
outcomes are more common the longer the pregnancy 
continues after the infants’ due date and they do not 
appear to be restricted to older mothers or low birthweight 
infants. While these results should not be viewed in isola-
tion, these data could usefully be provided to women as 
part of their decision-making with regard to IOL. Finally, 
further research is therefore needed to identify the path-
ways through which this effect is mediated, to ascertain 
appropriate intervention points and also establish the 
impact and risk/benefit ratio of pre-emptive birth.
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Apgar score
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OR (95% CI) OR (95% CI) OR (95% CI)
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